| Activated human neutrophils release hepatocyte growth factor/scatter factor. | |
| | |
MedLine Citation:
|
PMID: 11417987 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Hepatocyte growth factor or scatter factor (HGF/SF) is a pleiotropic cytokine that has potent angiogenic properties. We have previously demonstrated that neutrophils (PMN) are directly angiogenic by releasing vascular endothelial growth factor (VEGF). We hypothesized that the acute inflammatory response can stimulate PMN to release HGF. AIMS: To examine the effects of inflammatory mediators on PMN HGF release and the effect of recombinant human HGF (rhHGF) on PMN adhesion receptor expression and PMN VEGF release. METHODS: In the first experiment, PMN were isolated from healthy volunteers and stimulated with tumour necrosis factor-alpha (TNF-alpha), lipopolysaccharide (LPS), interleukin-8 (IL-8), and formyl methionyl-leucyl-phenylalanine (fMLP). Culture supernatants were assayed for HGF using ELISA. In the second experiment, PMN were lysed to measure total HGF release and HGF expression in the PMN was detected by Western immunoblotting. Finally, PMN were stimulated with rhHGF. PMN CD 11a, CD 11b, and CD 18 receptor expression and VEGF release was measured using flow cytometry and ELISA respectively. RESULTS: TNF-alpha, LPS and fMLP stimulation resulted in significantly increased release of PMN HGF (755+/-216, 484+/-221 and 565+/-278 pg/ml, respectively) compared to controls (118+/-42 pg/ml). IL-8 had no effect. Total HGF release following cell lysis and Western blot suggests that HGF is released from intracellular stores. Recombinant human HGF did not alter PMN adhesion receptor expression and had no effect on PMN VEGF release. CONCLUSIONS: This study demonstrates that pro-inflammatory mediators can stimulate HGF release from a PMN intracellular store and that activated PMN in addition to secreting VEGF have further angiogenic potential by releasing HGF. |
| | |
Authors:
|
M McCourt; J H Wang; S Sookhai; H P Redmond |
Related Documents
:
|
18948087 - Ppargamma agonist rosiglitazone is neuroprotective after traumatic brain injury via ant... 17412827 - Hepatocyte growth factor promotes colonic epithelial regeneration via akt signaling. 17631927 - 15d-pgj2 stimulates ho-1 expression through p38 map kinase and nrf-2 pathway in rat vas... 9821967 - Urokinase induces proliferation of human ovarian cancer cells: characterization of stru... 19923397 - Dietary plasma protein supplements prevent the release of mucosal proinflammatory media... 7917117 - Activation-induced apoptosis in lymphocytes. |
Publication Detail:
|
Type: In Vitro; Journal Article |
Journal Detail:
|
Title: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology Volume: 27 ISSN: 0748-7983 ISO Abbreviation: Eur J Surg Oncol Publication Date: 2001 Jun |
Date Detail:
|
Created Date: 2001-06-21 Completed Date: 2001-07-26 Revised Date: 2009-07-23 |
Medline Journal Info:
|
Nlm Unique ID: 8504356 Medline TA: Eur J Surg Oncol Country: England |
Other Details:
|
Languages: eng Pagination: 396-403 Citation Subset: IM |
Copyright Information:
|
Copyright Harcourt Publishers Limited. |
Affiliation:
|
Department of Surgery, Professorial Unit, Cork University Hospital, Cork, Ireland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analysis of Variance Blotting, Western Cell Adhesion Molecules / metabolism* Endothelial Growth Factors / metabolism* Enzyme-Linked Immunosorbent Assay Flow Cytometry Gene Expression Regulation / drug effects Hepatocyte Growth Factor / metabolism* Humans Interleukin-8 / pharmacology Lipopolysaccharides / pharmacology Lymphocyte Activation / drug effects Lymphokines / metabolism* N-Formylmethionine Leucyl-Phenylalanine / pharmacology Neovascularization, Pathologic Neutrophils / drug effects*, secretion* Tumor Necrosis Factor-alpha / pharmacology Vascular Endothelial Growth Factor A Vascular Endothelial Growth Factors |
| Chemical | |
Reg. No./Substance:
|
0/Cell Adhesion Molecules; 0/Endothelial Growth Factors; 0/Interleukin-8; 0/Lipopolysaccharides; 0/Lymphokines; 0/Tumor Necrosis Factor-alpha; 0/Vascular Endothelial Growth Factor A; 0/Vascular Endothelial Growth Factors; 59880-97-6/N-Formylmethionine Leucyl-Phenylalanine; 67256-21-7/Hepatocyte Growth Factor |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Regional toxicity after isolated limb perfusion with melphalan and tumour necrosis factor- alpha ver...
Next Document: (131)I-MIBG radionuclide therapy is safe and cost-effective in the control of symptoms of the carcin...